The European Commission calls for experts for evaluation, supervising and monitoring FP7 calls for proposal
Commission publishes 2011 Health Work Programme and calls for proposals of the 7th Framework Programme
On 20 July 2010, the European Commission Directorate General for Research published the 2011 Health Work Programme of the Seventh Framework Programme for research and technological development (FP7)
EASL 'PAST and PRESENT' 1966-2010
EASL Members: Request your free copy of the EASL history book
Press releases
2010-08-04
EASL 4th Clinical Practice Guidelines for the Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis
The European Association for the Study of the Liver
Geneva, Switzerland, August 4th: Today, the European Association for the Study of the Liver (EASL) – the leading European scientific society dedicated to promoting research and education in hepatology – has published clinical practice guidelines for the management of ascites, [...] Read more
2010-06-25
INTERNATIONAL LIVER CANCER CONGRESS PROVIDES POSSIBLE SOLUTIONS TO REDUCE SIGNIFICANT BURDEN
The European Association for the Study of the Liver
EMBARGOED UNTIL Friday, 25 June 2010 at 00.01 CETGeneva, Switzerland, Friday, 25 June 2010: Today, world renowned experts have assembled in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future [...] Read more
2010-05-21
EASL Prioritises Early Diagnosis in Call to Action to Make Hepatitis a European Health Priority
The European Association for the Study of the Liver
Geneva, Switzerland, Friday 21 May 2010: The European Association for the Study of the Liver (EASL) today reinforces its commitment to raising hepatitis on the European health agenda, as it endorses a call to action discussed at a high-level roundtable with Members of the [...] Read more
2010-05-19
World Hepatitis Day 2010 “Hepatitis – three years after the EP Written Declaration”
European Parliament Lunch Debate
Read more
2010-04-17
GENETIC SIGNATURES PROVIDE NEW DIRECTION IN LIVER CANCER
EASL - The International Liver Congress™ 2010, Vienna, Austria
Large patient cohort study shows genomic-based portrait that predicts liver cancer recurrence Vienna, Austria, Friday 16 April: Results of an international clinical study conducted in Europe and the US presented today at the International Liver Congress™ 2010, the annual meeting [...] Read more
2010-04-17
NEW STUDIES HELP ESTABLISH POTENTIAL OF ARTIFICIAL LIVER SUPPORT DEVICES
EASL - The International Liver Congress™ 2010, Vienna, Austria
Results show limited survival advantage, only in specific patient typesVienna, Austria, Friday 16th April 2010: Results from two studies presented today at the International Liver Congress™ 2010 have shown that treatment with extracorporeal devices may not confer a survival [...] Read more
2010-04-17
RESEARCH OFFERS NEW INSIGHTS INTO TREATMENT OPTIONS FOR PATIENTS WHO SUFFER FROM SEVERE ALCOHOLIC HEPATITIS
EASL - The International Liver Congress™ 2010, Vienna, Austria
Results from two new studies help inform future clinical practice Vienna, Austria, Friday 16 April 2010: Results from two French studies presented today at the International Liver Congress™ 2010 press conference will help inform clinical practice in the treatment of patients [...] Read more
2010-04-16
OVER 90% OF GENOTYPE 1 HEPATITIS C VIRUS PATIENTS WHO ACHIEVE AN EARLY VIRAL RESPONSE CAN BE SUCCESSFULLY TREATED WITHIN SIX MONTHS
EASL - The International Liver Congress™ 2010, Vienna, Austria
Vienna, Austria, Friday 16 April: 24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-naïve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) [...] Read more
2010-04-16
HIGH DOSE UDCA THERAPY DOES NOT IMPROVE OVERALL LIVER HISTOLOGY IN OBESITY RELATED HEPATITIS
EASL - The International Liver Congress™ 2010, Vienna, Austria
Encouraging results in one male subgroup may guide future clinical practice. Vienna, Austria, Friday 16 April: Results of a German study1 presented today at the International Liver Congress™ 2010, the annual meeting of the European Association for the Study of Liver in Vienna, [...] Read more
2010-04-16
NEW PHASE II STUDY SUPPORTS POTENTIAL OF GS-9450 AS NEW TREATMENT OPTION FOR STEATOHEPATITIS
EASL - The International Liver Congress™ 2010, Vienna, Austria
Results show highly significant dose dependent response. Vienna, Austria, Friday 16 April: Results from a multinational phase II study1 presented today at the International Liver Congress™ 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of [...] Read more